T. Rowe Price Investment Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-159,733
| Closed | -$31.8M | – | 652 |
|
|
2023
Q4 | $31.8M | Buy |
159,733
+3,246
| +2% | +$645K | 0.02% | 447 |
|
|
2023
Q3 | $20.8M | Buy |
156,487
+1,164
| +0.7% | +$155K | 0.01% | 472 |
|
|
2023
Q2 | $23.2M | Buy |
155,323
+1,350
| +0.9% | +$202K | 0.02% | 463 |
|
|
2023
Q1 | $22.6M | Sell |
153,973
-1,994
| -1% | -$293K | 0.02% | 459 |
|
|
2022
Q4 | $24.7M | Buy |
155,967
+383
| +0.2% | +$60.7K | 0.02% | 436 |
|
|
2022
Q3 | $29.9M | Buy |
+155,584
| New | +$29.9M | 0.02% | 406 |
|